Education
About Us
Working with TipRanks
Follow Us
Opko Health (OPK)
:OPK
Earnings Data
Report Date
Feb 19, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.06Last Year’s EPS
0.01Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects strong strategic moves such as the sale of non-core assets and significant partnerships, contributing to financial improvements and shareholder value. However, there are challenges in diagnostics revenue decline and slower-than-expected market conversion affecting Pfizer profit share.Company Guidance
Sale of BioReference Health's Oncology Division
Completed the sale of BioReference Health's oncology division, providing $192.5 million at closing and $32.5 million in performance-based earn-out, streamlining lab business for profitable growth.
Significant Partnerships for Therapeutics
Announced a research collaboration and license agreement with Regeneron, with milestone payments potentially totaling over $1 billion, and continued partnership with Merck on EBV vaccine development.
Stock Repurchase Program
Repurchased $25.1 million worth of stock in 2025, with $126 million remaining under the program, demonstrating commitment to increasing shareholder value.
4Kscore Test Growth
4Kscore test volume increased more than 20% in the third quarter compared to the previous year, with FDA label expansion opening new markets.
Improved Financial Performance
Consolidated operating income improved to $48.1 million from $14.2 million in 2024, driven by improved results at BioReference.
OPK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
OPK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 29, 2025 | $1.43 | $1.46 | +2.10% |
Jul 31, 2025 | $1.28 | $1.19 | -7.03% |
Apr 30, 2025 | $1.38 | $1.35 | -2.17% |
Feb 27, 2025 | $1.63 | $1.74 | +6.75% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Opko Health (OPK) report earnings?
Opko Health (OPK) is schdueled to report earning on Feb 19, 2026, After Close (Confirmed).
What is Opko Health (OPK) earnings time?
Opko Health (OPK) earnings time is at Feb 19, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OPK EPS forecast?
OPK EPS forecast for the fiscal quarter 2025 (Q4) is -0.06.